Korean J Physiol Pharmacol.  2017 Mar;21(2):225-232. 10.4196/kjpp.2017.21.2.225.

Nortriptyline, a tricyclic antidepressant, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells

• Shin SE
• Li H
• Kim HS
• Kim HW
• Seo MS
• Ha KS
• Han ET
• Hong SH
• Firth AL
• Choi IW
• Bae YM
• Park WS

• KMID: 2371041
• DOI: http://doi.org/10.4196/kjpp.2017.21.2.225

Abstract

We demonstrated the effect of nortriptyline, a tricyclic antidepressant drug and serotonin reuptake inhibitor, on voltage-dependent K⁺ (Kv) channels in freshly isolated rabbit coronary arterial smooth muscle cells using a whole-cell patch clamp technique. Nortriptyline inhibited Kv currents in a concentration-dependent manner, with an apparent ICâ‚…â‚€ value of 2.86±0.52 µM and a Hill coefficient of 0.77±0.1. Although application of nortriptyline did not change the activation curve, nortriptyline shifted the inactivation current toward a more negative potential. Application of train pulses (1 or 2 Hz) did not change the nortriptyline-induced Kv channel inhibition, suggesting that the effects of nortiprtyline were not use-dependent. Preincubation with the Kv1.5 and Kv2.1/2.2 inhibitors, DPO-1 and guangxitoxin did not affect nortriptyline inhibition of Kv channels. From these results, we concluded that nortriptyline inhibited Kv channels in a concentration-dependent and state-independent manner independently of serotonin reuptake.

Keyword

Coronary artery; Nortriptyline; Voltage-dependent K⁺ channel

MeSH Terms

Coronary Vessels
Muscle, Smooth*
Myocytes, Smooth Muscle*
Nortriptyline*
Serotonin
Nortriptyline
Serotonin

Figure

• 

  Fig. 1 Effects of nortriptyline on voltage-dependent K+ (Kv) channel currents.Representative Kv currents were elicited by 600-ms depolarizing step pulses from −60 to +60 mV in steps of 10-mV at a holding potential of −60 mV in the control condition (A) and in the presence of 10 µM nortriptyline (B). (C) The current-voltage (I~V) relationship at steady-state Kv current under control conditions (○) and in the presence of 10 µM nortriptyline (●). n=7. *p<0.05. (D) Voltage-dependence of Kv current inhibition by nortriptyline. Normalized inhibition shown as relative current from panel in (C) are plotted as a function of membrane potential.

• 

  Fig. 2 Concentration-dependent inhibition of Kv channels by nortriptyline.(A) Superimposed currents were elicited by 600-ms depolarizing pulse of +60 from a holding potential of −60 mV in the presence of 0, 0.1, 0.3, 1, 3, 10, 30, and 100 mM nortriptyline. (B) Concentration-dependent curve for nortriptyline-induced inhibition of the Kv current measured at steady-state. n=8.

• 

  Fig. 3 Influence of nortriptyline on steady-state activation and steady-state inactivation curves.(A) Activation currents in the absence (○) and presence of 10 µM nortriptyline (●). Tail currents were elicited by short depolarizing pulses (20~50 ms) from −80 to +60 mV in steps of 10 mV at a holding potential of −80 mV. Subsequent pulses returned to −40 mV. The current was normalized from the peak value of the tail current. n=10. (B) Inactivation currents in the absence (○) and presence of nortriptyline (●). The currents were elicited by a two-pulse protocol with a test step to +40 mV after 7-s conditioning pre-pulses between −80 and −30 mV. The elicited currents were normalized to the current of the peak test pulse. n=9. *p<0.05.

• 

  Fig. 4 The effects of pre-treatment with Kv1.5 and/or Kv2.1/2.2 inhibitors on the nortriptyline-induced inhibition of Kv current.Current traces were obtained by one-step depolarizing pulses to +60 mV at a holding potential of −60 mV. (A) Superimposed currents under control, in the presence of DPO-1, and in the presence of DPO-1+nortriptyline. (B) Summary of the results shown in panel (A). n=5. *p<0.05. (C) Superimposed currents under control, in the presence of guangxitoxin, and in the presence of guangxitoxin+nortriptyline. (D) Summary of the results shown in panel (C). n=5. *p<0.05. (E) Superimposed currents under control, in the presence of DPO-1+guangxitoxin, and in the presence of DPO-1+guangxitoxin+nortriptyline. (F) Summary of the results shown in panel (E). n=6. *p<0.05.

• 

  Fig. 5 Frequency-dependent inhibition of Kv currents by nortriptyline.Twenty depolarizing pulses from −60 mV to +60 mV in duration of 150-ms were applied in the absence (○) and presence of nortriptyline (●), at frequencies of 1 Hz (A) and 2 Hz (B). Each peak current was normalized by the peak current at first pulse and plotted against the pulse number. n=5.

Reference

1. van den Broek WW, Mulder PG, van Os E, Birkenhäger TK, Pluijms E, Bruijn JA. Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis. J Psychopharmacol. 2009; 23:708–713. PMID: 18562424.

2. von Wolff A, Hölzel LP, Westphal A, Härter M, Kriston L. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. J Affect Disord. 2013; 144:7–15. PMID: 22963896.

3. Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. 2014; (9):CD002018. PMID: 25211400.

4. Pomara N, Shao B, Choi SJ, Tun H, Suckow RF. Sex-related differences in nortriptyline-induced side-effects among depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25:1035–1048. PMID: 11444676.

5. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268:C799–C822. PMID: 7733230.

6. Standen NB, Quayle JM. K⁺ channel modulation in arterial smooth muscle. Acta Physiol Scand. 1998; 164:549–557. PMID: 9887977.

7. Ko EA, Han J, Jung ID, Park WS. Physiological roles of K⁺ channels in vascular smooth muscle cells. J Smooth Muscle Res. 2008; 44:65–81. PMID: 18552454.

8. Ko EA, Park WS, Firth AL, Kim N, Yuan JX, Han J. Pathophysiology of voltage-gated K⁺ channels in vascular smooth muscle cells: modulation by protein kinases. Prog Biophys Mol Biol. 2010; 103:95–101. PMID: 19835907.

9. Bae H, Lee D, Kim YW, Choi J, Lee HJ, Kim SW, Kim T, Noh YH, Ko JH, Bang H, Lim I. Effects of hydrogen peroxide on voltage-dependent K⁺ currents in human cardiac fibroblasts through protein kinase pathways. Korean J Physiol Pharmacol. 2016; 20:315–324. PMID: 27162486.

10. Bae YM, Kim A, Kim J, Park SW, Kim TK, Lee YR, Kim B, Cho SI. Serotonin depolarizes the membrane potential in rat mesenteric artery myocytes by decreasing voltage-gated K⁺ currents. Biochem Biophys Res Commun. 2006; 347:468–476. PMID: 16828462.

11. Archer SL, London B, Hampl V, Wu X, Nsair A, Puttagunta L, Hashimoto K, Waite RE, Michelakis ED. Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. FASEB J. 2001; 15:1801–1803. PMID: 11481235.

12. Cox RH, Folander K, Swanson R. Differential expression of voltage-gated K⁺ channel genes in arteries from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 2001; 37:1315–1322. PMID: 11358947.

13. Liu Y, Terata K, Rusch NJ, Gutterman DD. High glucose impairs voltage-gated K⁺ channel current in rat small coronary arteries. Circ Res. 2001; 89:146–152. PMID: 11463721.

Snyders DJ., Yeola SW. Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res. 1995. 77:575–583. PMID: 7641327.

15. Park WS, Ko JH, Kim N, Son YK, Kang SH, Warda M, Jung ID, Park YM, Han J. Increased inhibition of inward rectifier K⁺ channels by angiotensin II in small-diameter coronary artery of isoproterenol-induced hypertrophied model. Arterioscler Thromb Vasc Biol. 2007; 27:1768–1775. PMID: 17525364.

16. Malmgren R, Aberg-Wistedt A, Bertilsson L. Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolites. Psychopharmacology (Berl). 1987; 92:169–172. PMID: 2440073.

17. Watts SW. 5-HT in systemic hypertension: foe, friend or fantasy? Clin Sci (Lond). 2005; 108:399–412. PMID: 15831089.

18. Pomara N, Shao B, Choi SJ, Tun H, Suckow RF. Sex-related differences in nortriptyline-induced side-effects among depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25:1035–1048. PMID: 11444676.

19. Su S, Ohno Y, Lossin C, Hibino H, Inanobe A, Kurachi Y. Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline. J Pharmacol Exp Ther. 2007; 320:573–580. PMID: 17071817.

20. Terstappen GC, Pula G, Carignani C, Chen MX, Roncarati R. Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines. Neuropharmacology. 2001; 40:772–783. PMID: 11369031.

21. Yamakawa Y, Furutani K, Inanobe A, Ohno Y, Kurachi Y. Pharmacophore modeling for hERG channel facilitation. Biochem Biophys Res Commun. 2012; 418:161–166. PMID: 22244872.

22. Bardai A, Amin AS, Blom MT, Bezzina CR, Berdowski J, Langendijk PN, Beekman L, Klemens CA, Souverein PC, Koster RW, de Boer A, Tan HL. Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community. Eur Heart J. 2013; 34:1506–1516. PMID: 23425522.

23. Hong DH, Li H, Kim HS, Kim HW, Shin SE, Jung WK, Na SH, Choi IW, Firth AL, Park WS, Kim DJ. The effects of the selective serotonin reuptake inhibitor fluvoxamine on voltage-dependent K⁺ channels in rabbit coronary arterial smooth muscle cells. Biol Pharm Bull. 2015; 38:1208–1213. PMID: 26235584.

24. Kim HW, Li H, Kim HS, Shin SE, Jung WK, Ha KS, Han ET, Hong SH, Choi IW, Park WS. Cisapride, a selective serotonin 5-HT4-receptor agonist, inhibits voltage-dependent K⁺ channels in rabbit coronary arterial smooth muscle cells. Biochem Biophys Res Commun. 2016; 478:1423–1428. PMID: 27569285.

25. Lee HM, Hahn SJ, Choi BH. Blockade of Kv1.5 by paroxetine, an antidepressant drug. Korean J Physiol Pharmacol. 2016; 20:75–82. PMID: 26807026.

26. Lee HM, Hahn SJ, Choi BH. Blockade of Kv1.5 channels by the antidepressant drug sertraline. Korean J Physiol Pharmacol. 2016; 20:193–200. PMID: 26937216.

27. Xu C, Lu Y, Tang G, Wang R. Expression of voltage-dependent K⁺ channel genes in mesenteric artery smooth muscle cells. Am J Physiol. 1999; 277:G1055–G1063. PMID: 10564112.

28. Yuan XJ, Wang J, Juhaszova M, Golovina VA, Rubin LJ. Molecular basis and function of voltage-gated K⁺ channels in pulmonary arterial smooth muscle cells. Am J Physiol. 1998; 274:L621–L635. PMID: 9575881.

29. Lagrutta A, Wang J, Fermini B, Salata JJ. Novel, potent inhibitors of human Kv1.5 K⁺ channels and ultrarapidly activating delayed rectifier potassium current. J Pharmacol Exp Ther. 2006; 317:1054–1063. PMID: 16522807.

30. Zhao N, Dong Q, Du LL, Fu XX, Du YM, Liao YH. Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells. PLoS One. 2013; 8:e64629. PMID: 23717641.

31. Moral-Sanz J, Gonzalez T, Menendez C, David M, Moreno L, Macias A, Cortijo J, Valenzuela C, Perez-Vizcaino F, Cogolludo A. Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries. Am J Physiol Cell Physiol. 2011; 301:C186–C194. PMID: 21490312.

32. Tsvetkov D, Tano JY, Kassmann M, Wang N, Schubert R, Gollasch M. The role of DPO-1 and XE991-sensitive potassium channels in perivascular adipose tissue-mediated regulation of vascular tone. Front Physiol. 2016; 7:335. PMID: 27540364.

33. Jensen BP, Roberts RL, Vyas R, Bonke G, Jardine DL, Begg EJ. Influence of ABCB1 (P-glycoprotein) haplotypes on nortriptyline pharmacokinetics and nortriptyline-induced postural hypotension in healthy volunteers. Br J Clin Pharmacol. 2012; 73:619–628. PMID: 21999196.

34. Quayle JM, Dart C, Standen NB. The properties and distribution of inward rectifier potassium currents in pig coronary arterial smooth muscle. J Physiol. 1996; 494:715–726. PMID: 8865069.